Who Paid My Doc
Fedratinib
Drug
General payments
$78,349
Research payments
$276,897
Through program year 2019, $78,349 in general payments and $276,897 in research payments were reported against Fedratinib.
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | General | $78,349 | 124 |
| 2019 | Research | $276,897 | 14 |
Breakdown
The top 5 of 34 recipients; each share is of general payments naming this product in 2019.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.
The top 5 of 13 states; each share is of general payments naming this product in 2019 where a state was reported.
Records
124 general · 14 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.